FDA, Regulations

FDA Says ADHD Med Adderall Is in Short Supply

October 13, 2022


People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday. The Adderall and Adderall IR shortage is due to intermittent manufacturing delays at […]

Biotech, Industry

Akili digital therapeutic shows promise in lupus patients

July 15, 2022

Via: Pharmaphorum

The PureTech group company – which scored the first FDA and EMA approvals for a DTx for attention-deficit hyperactivity disorder (ADHD) – is developing AKL-T01 to tackle cognitive impairments that can affect people with SLE. Cognitive dysfunction occurs in between […]